Library Subscription: Guest
Critical Reviews™ in Oncogenesis

Published 4 issues per year

ISSN Print: 0893-9675

ISSN Online: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Lynch Syndrome and Related Familial Colorectal Cancers

Volume 14, Issue 1, 2008, pp. 1-22
DOI: 10.1615/CritRevOncog.v14.i1.10
Get accessGet access

ABSTRACT

Lynch syndrome (hereditary non-polyposis colorectal cancer, HNPCC) refers to autosomal dominant predisposition to colorectal, endometrial, and a spectrum of other cancers. The syndrome is due to heterozygous germ line mutations in one of the mismatch repair genes MLH1, MSH2, MSH6, and PMS2. Amsterdam I and II criteria for clinical diagnosis and Bethesda guidelines for molecular testing of suspected patients usually point out additional families in which there is no evidence of mismatch repair deficiency even after screening by microsatellite instability analysis and/or immunohistochemistry for mismatch repair proteins. Hence, the term "Lynch syndrome" should be restricted to those families with germ line mutations in one of the mismatch repair genes. Familial colorectal tumors with no evidence of mismatch repair deficiency were shown to be clinically and molecularly distinct from classical Lynch syndrome tumors and, therefore, were designated "familial colorectal cancer type X" (FCC-X). The predisposing gene(s) to FCC-X is as yet unknown, but extensive research is currently underway to delineate its etiology. Given the above distinctions, the term hereditary nonpolyposis colorectal cancer (HNPCC), which was formerly used to refer to clinically diagnosed colorectal cancer families that might or might not have mismatch repair deficiency, is being replaced by one of the more informative names: Lynch syndrome and FCC-X.

CITED BY
  1. Pinar Gul, Ayhan Ali, Carcinomas Associated With Lynch Syndrome: A Family History, International Surgery, 96, 4, 2011. Crossref

  2. Neumaier Christian, Nittka Stefanie, Neumaier Michael, Loss of Expression of the Tumor Suppressor CEACAM1 Links Different Hereditary Colorectal Carcinoma Subtypes to the Genesis of Sporadic Colorectal Carcinoma, Onkologie, 35, 10, 2012. Crossref

  3. Therkildsen Christina, Jönsson Göran, Dominguez-Valentin Mev, Nissen Anja, Rambech Eva, Halvarsson Britta, Bernstein Inge, Borg Åke, Nilbert Mef, Gain of chromosomal region 20q and loss of 18 discriminates between Lynch syndrome and familial colorectal cancer, European Journal of Cancer, 49, 6, 2013. Crossref

  4. Jarzen John, Diamanduros Andrew, Scarpinato Karin D., , 60, 2013. Crossref

  5. Warden G, Harnett D, Green J, Wish T, Woods MO, Green R, Dicks E, Rahman P, Zhai G, Parfrey P, A population-based study of hereditary non-polyposis colorectal cancer: evidence of pathologic and genetic heterogeneity, Clinical Genetics, 84, 6, 2013. Crossref

  6. Cossio Silvia Liliana, Koehler-Santos Patricia, Pessini Suzana Arenhart, Mónego Heleuza, Edelweiss Maria Isabel, Meurer Luise, Errami Abdellatif, Coffa Jordy, Bock Hugo, Saraiva-Pereira Maria Luiza, Ashton-Prolla Patricia, Prolla João Carlos, Clinical and histomolecular endometrial tumor characterization of patients at-risk for Lynch syndrome in South of Brazil, Familial Cancer, 9, 2, 2010. Crossref

  7. Umeda Yuzo, Nagasaka Takeshi, Mori Yoshiko, Sadamori Hiroshi, Sun Dong-Sheng, Shinoura Susumu, Yoshida Ryuich, Satoh Daisuke, Nobuoka Daisuke, Utsumi Masashi, Yoshida Kazuhiro, Yagi Takahito, Fujiwara Toshiyoshi, Poor prognosis ofKRASorBRAFmutant colorectal liver metastasis without microsatellite instability, Journal of Hepato-Biliary-Pancreatic Sciences, 20, 2, 2013. Crossref

  8. Valle Laura, Hernández-Illán Eva, Bellido Fernando, Aiza Gemma, Castillejo Adela, Castillejo María-Isabel, Navarro Matilde, Seguí Nuria, Vargas Gardenia, Guarinos Carla, Juarez Miriam, Sanjuán Xavier, Iglesias Silvia, Alenda Cristina, Egoavil Cecilia, Segura Ángel, Juan María-José, Rodriguez-Soler María, Brunet Joan, González Sara, Jover Rodrigo, Lázaro Conxi, Capellá Gabriel, Pineda Marta, Soto José Luís, Blanco Ignacio, New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis, Human Molecular Genetics, 23, 13, 2014. Crossref

  9. Kirienko Natalia V., Mani Kumaran, Fay David S., Cancer models inCaenorhabditis elegans, Developmental Dynamics, 2010. Crossref

  10. Shalin Sara C, Lyle Stephen, Calonje Eduardo, Lazar Alexander J F, Sebaceous neoplasia and the Muir–Torre syndrome: important connections with clinical implications, Histopathology, 56, 1, 2010. Crossref

  11. Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR, Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications, Clinical Genetics, 76, 1, 2009. Crossref

  12. Bregenhorn S., Jiricny J., Biochemical characterization of a cancer-associated E109K missense variant of human exonuclease 1, Nucleic Acids Research, 42, 11, 2014. Crossref

  13. Kovac Michal, Laczko Endre, Haider Ritva, Jiricny Josef, Mueller Hansjakob, Heinimann Karl, Marra Giancarlo, Familial colorectal cancer: eleven years of data from a registry program in Switzerland, Familial Cancer, 10, 3, 2011. Crossref

  14. Harris Reuben S, Molecular mechanism and clinical impact of APOBEC3B-catalyzed mutagenesis in breast cancer, Breast Cancer Research, 17, 1, 2015. Crossref

  15. Preston Bradley D., Albertson Tina M., Herr Alan J., DNA replication fidelity and cancer, Seminars in Cancer Biology, 20, 5, 2010. Crossref

  16. Germini Demétrius Eduardo, Mader Ana Maria Amaral Antônio, Gomes Luiz Guilherme Lisboa, Teodoro Thérèse Rachel, Franco Maria Isete Fares, Waisberg Jaques, Detection of DNA repair protein in colorectal cancer of patients up to 50 years old can increase the identification of Lynch syndrome?, Tumor Biology, 37, 2, 2016. Crossref

  17. Ivan Doina, Prieto Victor G., Aung Phyu, Use of Immunohistochemical and Molecular Studies in the Evaluation of the Sebaceous Neoplasms, in Applied Immunohistochemistry in the Evaluation of Skin Neoplasms, 2016. Crossref

  18. Valle Laura, Genetic predisposition to colorectal cancer: Where we stand and future perspectives, World Journal of Gastroenterology, 20, 29, 2014. Crossref

  19. Valle Laura, Debate aboutTGFBR1and the susceptibility to colorectal cancer, World Journal of Gastrointestinal Oncology, 4, 1, 2012. Crossref

  20. Arana Mercedes E., Holmes Shannon F., Fortune John M., Moon Andrea F., Pedersen Lars C., Kunkel Thomas A., Functional residues on the surface of the N-terminal domain of yeast Pms1, DNA Repair, 9, 4, 2010. Crossref

  21. Ivan Doina, Aung Phyu P., Molecular Pathology of Cutaneous Adnexal Tumors, in Precision Molecular Pathology of Dermatologic Diseases, 9, 2015. Crossref

  22. Alvarez Karin, Hurtado Claudia, Hevia Montserrat A., Wielandt Ana Maria, de la Fuente Marjorie, Church James, Carvallo Pilar, López-Köstner Francisco, Spectrum of MLH1 and MSH2 Mutations in Chilean Families With Suspected Lynch Syndrome, Diseases of the Colon & Rectum, 53, 4, 2010. Crossref

  23. Fearon Eric R., Molecular Genetics of Colorectal Cancer, Annual Review of Pathology: Mechanisms of Disease, 6, 1, 2011. Crossref

  24. Beech Cameron, Hechtman Jaclyn F., Molecular Approach to Colorectal Carcinoma, Surgical Pathology Clinics, 14, 3, 2021. Crossref

  25. Valle Laura, Recent Discoveries in the Genetics of Familial Colorectal Cancer and Polyposis, Clinical Gastroenterology and Hepatology, 15, 6, 2017. Crossref

  26. Kong Jiangying, Liu Zhuo, Cai Feng, Xu Xiaocheng, Liul Jun, Relationship between the Asp1104His polymorphism of the nucleotide excision repair gene ERCC5 and treatment sensitivity to oxaliplatin in patients with advanced colorectal cancer in China, Clinics, 73, 2018. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain